Company Description
Gage Growth (OTC: GAEGF) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $193.8M.
GAEGF stock has declined 21.8% over the past year.
This page provides a comprehensive overview of GAEGF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Gage Growth (GAEGF) stock. Over the past 12 months, the stock has lost 21.8%. At a market capitalization of $193.8M, GAEGF is classified as a micro-cap stock with approximately 137.8M shares outstanding.
Latest News
Gage Growth has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition. View all GAEGF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GAEGF Company Profile & Sector Positioning
Gage Growth (GAEGF) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector.
Investors comparing GAEGF often look at related companies in the same sector, including (MNKPF), (LNDC), (GNTW), (REPH), and (HBORF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GAEGF's relative position within its industry.